257 related articles for article (PubMed ID: 19647628)
1. Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment.
Yoon M; Shin D; Kwak J; Park S; Lim YK; Kim D; Park SY; Lee SB; Shin KH; Kim TH; Cho KH
Med Dosim; 2009; 34(3):191-201. PubMed ID: 19647628
[TBL] [Abstract][Full Text] [Related]
2. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
3. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
4. Intrafractional motion during proton beam scanning.
Lambert J; Suchowerska N; McKenzie DR; Jackson M
Phys Med Biol; 2005 Oct; 50(20):4853-62. PubMed ID: 16204877
[TBL] [Abstract][Full Text] [Related]
5. Breathing interplay effects during proton beam scanning: simulation and statistical analysis.
Seco J; Robertson D; Trofimov A; Paganetti H
Phys Med Biol; 2009 Jul; 54(14):N283-94. PubMed ID: 19550002
[TBL] [Abstract][Full Text] [Related]
6. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.
Newhauser W; Fontenot J; Zheng Y; Polf J; Titt U; Koch N; Zhang X; Mohan R
Phys Med Biol; 2007 Aug; 52(15):4569-84. PubMed ID: 17634651
[TBL] [Abstract][Full Text] [Related]
9. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
10. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
[TBL] [Abstract][Full Text] [Related]
11. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
12. Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment.
Yoon M; Kim D; Shin DH; Park SY; Lee SB; Kim DY; Kim JY; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1091-102. PubMed ID: 18234429
[TBL] [Abstract][Full Text] [Related]
13. Towards an objective evaluation of tolerances for beam modeling in a treatment planning system.
Rangel A; Ploquin N; Kay I; Dunscombe P
Phys Med Biol; 2007 Oct; 52(19):6011-25. PubMed ID: 17881816
[TBL] [Abstract][Full Text] [Related]
14. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric impact of a CT metal artefact suppression algorithm for proton, electron and photon therapies.
Wei J; Sandison GA; Hsi WC; Ringor M; Lu X
Phys Med Biol; 2006 Oct; 51(20):5183-97. PubMed ID: 17019032
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
Vynckier S; ;
Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
[TBL] [Abstract][Full Text] [Related]
17. A potential method for in vivo range verification in proton therapy treatment.
Lu HM
Phys Med Biol; 2008 Mar; 53(5):1413-24. PubMed ID: 18296770
[TBL] [Abstract][Full Text] [Related]
18. Image guidance based on prostate position for prostate cancer proton therapy.
Vargas C; Wagner M; Indelicato D; Fryer A; Horne D; Chellini A; McKenzie C; Lawlor P; Mahajan C; Li Z; Lin L; Keole S
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1322-8. PubMed ID: 18472365
[TBL] [Abstract][Full Text] [Related]
19. Effect of transverse magnetic fields on dose distribution and RBE of photon beams: comparing PENELOPE and EGS4 Monte Carlo codes.
Nettelbeck H; Takacs GJ; Rosenfeld AB
Phys Med Biol; 2008 Sep; 53(18):5123-37. PubMed ID: 18723929
[TBL] [Abstract][Full Text] [Related]
20. Out-of-field dose equivalents delivered by passively scattered therapeutic proton beams for clinically relevant field configurations.
Wroe A; Clasie B; Kooy H; Flanz J; Schulte R; Rosenfeld A
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):306-13. PubMed ID: 19100924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
